GLP1R and type 2 diabetes mellitus: Another extensively studied aspect is pancreatic injury, as some studies have shown that patients with T2DM taking GLP-1 RAs exhibited a higher incidence of hyperamylasaemia or hyperlipasaemia than controls [64].